Abstract
Human adenoviruses have been used extensively as a model for studies on the mechanism of oncogenic transformation. The interest in this group of viruses is due to the fact that they combine a number of unique features, that are not found in other viruses: (a) Oncogenic transformation by adenoviruses is the result of the activity of 2 or 3 distinct viral gene products, rather than by the action of a single viral protein, as in the case of SV40. This seemingly greater complexity of the transforming region of adenovirus is an advantage rather than a disadvantage. It should considerably simplify genetic and functional analysis of transformation as compared to the situation in SV40, where the transforming functions are all compressed into a single multifunctional protein (1). (b) Oncogenic transformation by adenoviruses can be considered to be a “multistep” process in which 2 or 3 genes are involved (2). This resembles the situation in spontaneous cancer in animals, which also requires the concerted activity of two, or possibly more, cellular oncogenes. Interestingly, a functional similarity has been established between the adenovirus E1A and E1B regions on one hand, which together constitute the viral transforming region, and the two cooperating cellular oncogenes myc and ras on the other (3,4). (c) The human adenoviruses can be divided into oncogenic and non-oncogenic serotypes (e.g. Ad 12, an oncogenic virus, and Ad2 or Ad5, both non-oncogenic viruses). Despite this difference in biological behavior, all human adenoviruses tested so far are capable of morphologically transforming cultured cells. The structural and organizational relatedness of the Ad5 and Ad 12 transforming regions implies that the difference in oncogenicity must be brought about by one or more subtle differences in gene function, and may enable us to dissociate oncogenicity, i.e. the ability to grow as a tumor in normal animals, from morphological transformation in vitro.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Tooze J: DNA Tumor Viruses. 2nd edition. Cold Spring Harbor Laboratory. 1981.
Van der Eb AJ, Van Ormondt H, Schrier PI, Lupker JH, Jochemsen H, DeLeys RJ, Maat J, Van Beveren, CP, Dijkema R, de Waard A: Structure and function of the transformed genes of human adenoviruses and SV40. Cold Spring Harbor Symp Quant Biol (44): 383–399, 1979.
Land H, Parada LF, Weinberg RA: Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature (304):596–602, 1979.
Ruley HE: Adenovirus region 1A enables viral and cellular transforming genes to transform primary cells in cultures. Nature (304): 602–606, 1983.
Bernards R, Houweling A, Schrier PI, Bos JL, Van der Eb AJ: Characterization of cells transformed by Ad5/Adl2 hybrid early region 1 plasmids. Virology (120): 422–432, 1982.
Bernards R, Schrier PI, Houweling A, Bos JL, Van der Eb AJ, Zijlstra M, Melief CJM: Tumorigenicity of cells transformed by adenovirus type 12 by evasion of T-cell immunity. Nature (305): 776–779, 1983.
Eddy BE, Grubbs GE, Young RD: Tumor immunity in hamsters infected with adenovirus 12 or simian virus 40. Proc Soc Exp Biol Med (117): 575–579, 1964.
Trentin JJ, Bryan E: Virus-induced transplantation immunity to human adenovirus type 12 tumors of the hamster and mouse. Proc Soc Exp Biol Med (121) 1216–1219, 1966.
Sjögren HO, Minowada J, Ankerst J: Specific transplantation antigens of mouse sarcomas induced by adenovirus type 12. J Exp Med (25): 689–701, 1967.
Shiroki K, Shimojo H, Maeta Y, Hamada C: Tumor-specific transplantation and surface antigen in cellc transformed by the adenovirus 12 DNA fragments. Virology (99): 188–191, 1979.
Raska K, Morrongiello MP, Föhring B: Adenovirus type 12 tumor antigen. III. Tumorigenicity and immune response to syngeneic rat cells transformed with virions and isolated transforming fragment of adenovirus 12 DNA. Int J Cancer (26): 79–86, 1980.
Raska K, Dougherty J, Gallimore PH: Product of adenovirus type 2 early gene block El in transformed cells elicits cytolytic response in syngeneic rats. Virology (117): 530–535, 1982.
Schrier PI, Bernards R, Vaessen RTMJ, Houweling A, Van der Eb AJ: Expression of class I major histocompatibility antigens switched off by highly oncogenic adenovirus 12 in transformed rat cells. Nature (305): 771–775, 1983.
Van der Eb AJ, Bernards R, Schrier PI, Bos JL, Vaessen RTMJ, Jochemsen AG, Melief CJM: Altered expression of cellular gene in adenovirus-transformed cells, in: Van de Woude GF et al. (eds). Cancer Cells 2, Cold Spring Harbor Laboratory, 1984, pp 501–510.
Sood AK, Pereira D, Weissman SM: Isolation and partial nucleotide sequence of a cDNA clone for human histocompatibility antigen HLA-B by use of an oligodeoxynucleotide primer. Proc Natl Acad Sci USA (78): 616–620, 1981.
Van Ormondt H, Galibert F: Nucleotide sequences of adenovirus DNAs. Curr Topics Microbiol Immunol (110): 73–142, 1984.
Pettersson U, Virtanen A, Perricaudet M, Akusjärvi G: The messenger RNAs from the transforming region of human adenoviruses. Curr Topics Microbiol Immunol (109): 107–123, 1983.
Bos JL, Jochemsen AG, Schrier PI, Van Ormondt H, Van der Eb AJ: Deletion mutants of region E1A of Adl2 El plasmids: effect of oncogenic transformation. Virology (129): 393–400, 1983.
Jochemsen AG, Bos JL, Van der Eb AJ: The first exon of region E1A genes of adenoviruses 5 and 12 encodes a separate functional protein domain. EMBO J (3): 2923–2927, 1984.
Vaessen RTMJ, Bernards R, Oostra BA, Houweling A, Jochemsen AG, Bos JL, Van der Eb AJ: Expression of MHC genes in adenovirus:transformed cells. In: Bishop JM, Rowley JD and Greaves M (eds) Genes and Cancer. Alan R.Liss, Inc., New York 1984, pp 303–314.
Bernards R, Schrier PI, Bos JL, Van der Eb AJ: Role of adenovirus type 5 and 12 early region lb tumor antigens in oncogenic transformation. Virology (127): 45–53, 1983.
Mellow G, Föhring B, Dougherty T, Gallimore PH, Raska K: Tumorigenicity of adenovirus-transformed rat cells and expression of class I major histocompatibility antigens. Virology (134): 460–465, 1984.
Grosveld F, personal communication.
Yabe Y, Trentin JJ, Grant T: Cancer induction in hamsters by human type 12 adenovirus. Effect of age and of virus dose. Proc Soc Exp Biol Med (111): 343–344, 1982.
Kirschstein RL, Rabson AS, Peters EA: Oncogenic activity of adenovirus 12 in thymectonized BALB/c and C3H/HeN mice. Proc Soc Exp Biol Med (117): 198–200, 1964.
Yohn DS, Funk CA, Kalninus VI, Grace JT: Sex-related resistance in hamsters to adenovirus 12 oncogenesis. Influence of thymectomy at three weeks of age. J Natl Cancer Inst (35): 617–624, 1965.
Yohn DS, Funk CA, Grace JTf Sex-related resistance in hamsters to adenovirus 12 oncogenesis. III. Influence of immunologic impairment by thymectomy or cortisone. J Immunol (100): 771–780, 1968.
Allison AC, Berman LD, Levey RH: Increased tumor induction by adenovirus type 12 in thymectonized mice and mice treated with anti-lymphocyte serum. Nature (215): 185–187, 1967.
Harwood, LMJ, Gallimore PH: A study on the oncogenicity of adenovirus type 2-transformed rat embryo cells. Int J Cancer (16): 498–508, 1975.
Van den Elsen P, De Pater S, Houweling A, Van der Eb AJ: The relationship between region Ela and Elb of human adenoviruses in cell transformation. Gene (18): 175–185, 1982.
Gallimore PH, McDougall JK, Chen LB: In vitro traits of adenovirus-transformed cell lines and their relevance to tumorigenicity in nude mice. Cell (10): 669–678, 1977.
Cook JL, Lewis AM: Host response to adenovirus 2-transformed hamster embryo cells. Cancer Res (39): 1455–1461, 1979.
Lewis AM, Cook JL: Spectrum of tumorigenic phenotypes among adenovirus 2, adenovirus 12 and simian virus 40-transformed Syrian hamster cells defined by host cellular immune-tumor cell interactions. Cancer Res (42): 939–944, 1982.
Lewis AM, Cook JL: The interphase between adenovirus-transformed cells and cellular immune response in the challanged host. Curr Toppics Microbiol Immunol (110): 1–22, 1984.
Graham FL, Abrahams PJ, Mulder C, Heyneker HL, Warnaar SO, De Vries FAJ, Fiers W, Van der Eb AJ: Studies on in vitro transformation by DNA and DNA fragments of human adenoviruses and simian virus 40. Cold Spring Harbor Symp Quant Biol (39): 637–650, 1974.
Gallimore PH, Paraskeva C: A study to determine the reasons for difference in the tumorigenicity of rat cell lines transformed by adenovirus 2 and adenovirus 12. Cold Spring Harbor Symp Quant Biol (44):703–713, 1980.
Yabe Y, Samper I, Bryan E, Taylor G, Trentin JJ: Oncogenic effect of human adenovirus type 12 in mice. Science (143): 46–47, 1964.
Zinkernagel RM, Doherty PC. Restriction of in vitro T cell-mediated cytotoxity in lymphocytic choriomeningitis within a syngeneic or semi-allogeneic system. Nature (248) 701–702, 1974.
Zinkernagel RM, Oldstone MB: Cells that express viral antigens but lack H-2 determinants are not lysed by immune thymus-derived lymphocytes but are lysed by other antiviral immune attack mechanisms. Proc Natl Acad Sci USA (73): 3666–3670, 1976.
Föhring B, Gallimore PH, Mellow GH, Raska K: Adenovirus type 12 specific cell surface antigen in transformed cells is a product of the Elb early region Virology (131): 463–472, 1983.
Tanaka K, Isselbacker KJ, Khoury G, Jay G: Reversal of oncogenesis by the expression of a MHC class I gene. Science in press, 1985.
Raska K, Gallimore P H: An inverse relation of the oncogenic potential of adenovirus-transformed cells and their sensitivity to killing by syngeneic natural killer cells. Virology (123): 8–18, 1982.
Cook JL, Hibbs JB, Lewis AM: DNA virus-transformed hamster cell-host effector cell interactions: level of resistance to cytolysis correlated with tumorigenicity. Int J Cancer (30): 795–803, 1982.
Cook JL, Lewis AM: Differential NK cell and macrophage killing of hamster cells infected with non-oncogenic and oncogenic adenoviruses. Science (224): 612–614, 1984.
Sheil JM, Gallimore PH, Zimmer SG, Sopori ML. Susceptibility of adenovirus transformed rat cell lines to natural killer (NK) cells: direct correlation between NK resistance and in vivo tumourigenesis. J.Immunol (132): 1578–1582, 1984.
Cook JL, Hauser J, Patch C, Lewis AM, Levine AS: Adenovirus 2 early gene expression promoter susceptibility to effector cell lysis of hybrids formed between adenovirus 2 and simian virus 40-transformed hamster cells. Proc Natl Acad Sci USA (80): 5995–5999, 1983.
Herberman RB, Holden HT: Natural cell-mediated immunity. Adv Cancer Res (27) 305–377, 1978.
Gooding LR: Characterization of a progressive tumor from CSH fibroblast transformed in vitro with SV40 virus. Immunoresistance in vivo correlates with phenotypic loss of H-2Kk J Immunol (129): 1306–1312, 1982.
Hui K, Grosveld F, Festenstein H: Rejection of transplantable AKR leukemia cells following MHC DNA-mediated cell transformation. Nature (311): 750–752, 1984.
Houweling A, Van den Elsen PJ, Van der Eb AJ: Partial transformation of primary rat cells by the leftmost 4.5% fragment of adenovirus 5 DNA. Virology (105) 537–550, 1980.
Van den Elsen PJ, Houweling A, Van der Eb AJ: Morphological transformation of human adenoviruses is determined to a large extent by gene products of region Ela. Virology (131): 242–246, 1983
Jones, N, Shenk T: Isolation of adenovirus type 5 hrt host range deletion mutants defective for transformation of rat embryo cells. Cell (17): 683–689, 1979.
Berk AJ, Lee F, Harrison T, Williams J, Sharp PA: Pre-early adenovirus 5 gene product regulate synthesis of early viral messenger RNAs. Cell (17): 935–944, 1979.
Nevins JR: Mechanism of activation of early viral transcription by the adenovirus E1A gene products. Cell (26): 213–220, 1981.
Ricciardi RP, Jones RL, Cepko CL, Sharp PA, Roberts BE: Expression of early adenovirus genes requires a viral-encoded acidic polypeptide. Proc Natl Acad Sci USA (78): 6121–6125, 1981.
Montell C, Fisher EF, Caruthers MH, Berk AJ: Resolving the functions of overlapping viral genes by site-specific mutagenesis at mRNA splice site. Nature (295): 380–384, 1982.
Carlock LR, Jones NC: Transformation-defective mutant of adenovirus type 5 containing a single altered Ela mRNA species. J Virol (40): 657–664, 1981.
Shenk T, Jones N, Colby W, Fowlkes D: Functional analysis of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells. Cold Spring Harbor Symop Quant Biol (44): 367–375, 1979.
Katze MG, Persson H, Philipson L: Control of adenovirus early gene expression: a post-transcriptional control mediated by region Ela products. Mol Cell Biol (1): 807–813, 1981.
Katze MG, Persson H, Johansson BM, Philipson L: Control of adenovirus gene expression: cellular gene products restrict expression of adenovirus host-range mutants in non-permissive cells. J Virol (46): 50–59, 1983.
Gaynor RB, Berk AJ: Cis-acting induction of adenovirus transcription Cell (33): 683–693, 1983.
Nevins JR: Induction of the synthesis of a 70.000 dalton mammalian heat shock protein by the adenovirus E1A gene product. Cell (29): 913–919, 1982.
Kao HT, Nevins JR: Transcriptional activation and subsequent control of the human heat shock gene during adenovirus infection. Mol Cell Biol (3): 2058–2065, 1983.
Stein R, Ziff EB: HeLa cell -tubilin gene transcription by adenovirus 5 in paralel with viral early genes by an E1A dependent mechanism. Mol Cell Biol (4): 2792–2801, 1984.
Beltz GA, Flint SJ: Inhibition of HeLa cell protein synthesis during adenovirus infection: restriction of cellular messenger RNA sequences to the nucleus. J Mol Biol (131): 353–373, 1979.
Bos JL, Ten Wolde-Kraamwinkel HC: The Elb promoter of Ad 12 in mouse L tk cells is activated by adenovirus region Ela. EMBO J (2): 73–76, 1983.
Green MR, Treisman R, Maniatis T: Transcriptional activation of cloned human -globin genes by viral intermediate-early gene products. Cell (35) 137–148, 1983.
Svenson C, Akusjärvi G: Adenovirus 2 early region E1A stimulates expression of both viral and cellular genes. EMBO J (3): 789–794, 1984.
Gaynor RB, Hillman D, Berk AJ: Adenovirus early region 1A protein activates transcription of a nonviral gene introduced into mammalian cells by infection or transfection. Proc Natl Acad Sci USA (81): 1193–1197, 1984.
Curtois G, Berk A: Adenovirus E1A protein activation of an integrated viral gene. Embo J (3): 1145–1149, 1984.
Baker CC, Ziff EB: Promoters and heterogeneous 5’ termini of the messenger RNAs of adenovirus serotype 2. J Mol Biol (149) 189–221, 1983.
Borelli E, Hen R, Chambon P: Adenovirus 2 E1A products repress enhancer-induced stimulation of transcription. Nature (312): 608–612, 1984.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Martinus Nijhoff Publishing, Boston
About this chapter
Cite this chapter
van der Eb, A.J., Oostra, B.A. (1986). Expression of Class I Major Histocompatibility Antigens in Adenovirus-Transformed Cells. In: Doerfler, W. (eds) Adenovirus DNA. Developments in Molecular Virology, vol 8. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2293-1_10
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2293-1_10
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9413-9
Online ISBN: 978-1-4613-2293-1
eBook Packages: Springer Book Archive